Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 268.95 Million | USD 386.91 Million | 4.7% | 2022 |
FrequentlyAsked Questions
The chemical compound form of metformin is metformin hydrochloride which is used to control high blood sugar in patients with type 2 diabetes.
The global Metformin hydrochloride market is projected to grow owing to the growing number of people living with type 2 diabetes.
According to study, the global metformin hydrochloride market size was worth around USD 268.95 million in 2022 and is predicted to grow to around USD 386.91 million by 2030.
The CAGR value of the metformin hydrochloride market is expected to be around 4.7% during 2023-2030.
The global metformin hydrochloride market is expected to be led by Asia-Pacific during the forecast period.
The global metformin hydrochloride market is led by players like Shouguang Fukang Pharmaceutical, CR Double-Crane, Wanbury, Keyuan Pharmaceutical, Aarti Drugs, Farmhispania Group, Harman Finochem, Exemed Pharmaceuticals, Vistin Pharma, Shijiazhuang Polee Pharmaceutical, and USV.
The global metformin hydrochloride market explores crucial aspects of the metformin hydrochloride market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the metformin hydrochloride market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed